Angiotensin-Converting Enzyme Genotypes and Risk for Myocardial Infarction in Women
- 15 March 1998
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 31 (4), 790-796
- https://doi.org/10.1016/s0735-1097(98)00007-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese.Circulation, 1994
- Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.JCI Insight, 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992
- Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.JCI Insight, 1992
- PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)Nucleic Acids Research, 1992
- Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.Circulation Research, 1991
- Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture.Hypertension, 1990
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- Angiotensin-converting enzyme: new concepts concerning its biological roleBiochemistry, 1989